The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic Dermatitis
Not Applicable
Recruiting
- Conditions
- Dermatitis, AtopicPruritus
- Interventions
- Other: 3% kanuka oil
- Registration Number
- NCT06488742
- Lead Sponsor
- Nexgen Dermatologics, Inc.
- Brief Summary
Atopic dermatitis is a common disease affecting millions worldwide. A common associated symptom in this population is pruritus. We seek to investigate the use of an natural, over-the-counter cosmeceutical to help this population
- Detailed Description
There are many treatment options available for atopic dermatitis yet many patients still suffer from the underlying symptomatology. It is important to explore other treatment alternatives to help this population.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- age greater than 12 years, diagnosis of atopic dermatitis for longer than 2 years, investigator's static global assessment score of either 2 or 3, and initial worst itch numerical rating scale (WI-NRS) for itch greater than 4.
Exclusion Criteria
- the use of topical or systemic corticosteroids within 28 days of entering the study, the use of any other non-emollient therapy within 28 days of entering the study,nursing, and pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 3% Kanuka Oil Cream 3% kanuka oil 3% kanuka oil cream will be applied topically to the affected area twice a day for 28 days 1% Hydrocortisone Cream 3% kanuka oil 1% Hydrocortisone Cream will be applied topically to the affected area twice a day for 28 days
- Primary Outcome Measures
Name Time Method ISGA 28 days Investigator scale to determine imporvement in condition
WI-NRS 28 days Scale generated by patient's responses to survey questions to assess improvement in itch
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Berlin Center
🇺🇸Boynton Beach, Florida, United States